You are on page 1of 1

Research Directions at the American Society of Clinical Oncology

By Dr. Gary Cecchi The American Society of Clinical Oncology, or ASCO, bases its primary interests and objectives in cancer and pharmaceutical research incentives. Current research aims ASCO pursues include a partnership with the National Cancer Institute, the Food and Drug Administration, and other respected organizations in evaluating conditions for new cancer drug approvals and protocols for clinical trials. ASCO additionally collaborates with the National Cancer Institute on its Cooperative Group Program introduced in the March 2010 Institute of Medicine report. The organization further demonstrates its interest in clinical trial processes by preparing a series of journal articles dedicated to improving oncology research programs. Set for release in ASCO's Journal of Oncology Practice, the articles offer resources based on the Statement on Minimum Standards and Attributes of Exemplary Clinical Trial Sites. About the Author: Dr. Gary Cecchi, a board-certified hematologist serving patients in Martinez, California, holds ongoing professional membership in the American Society of Clinical Oncology, along with membership in several other medical organizations. Having graduated with his MD from Tufts University School of Medicine in Boston, Maryland, Dr. Cecchi furnishes more than 23 years of medical experience.